OpenVSafe by OpenVAERS
Search V-safe

2CU-29857-97554

5 vaccinations 8 coded responses 65 check-ins 7 free-text entries 4 call cases
Sex
Female
Age at first dose
51-55
ZIP prefix
224 / VA
Registered
2021-02-07
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-06
    Dose 1 — Pfizer-BioNTech
  2. 2021-02-07
    Registered in v-safe
  3. 2021-02-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Swelling · Chills, Headache, Fatigue or tiredness
    Adult check-in
  4. 2021-02-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache, Fatigue or tiredness
    Adult check-in
  5. 2021-02-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache, Fatigue or tiredness
    Adult check-in
  6. 2021-02-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-02-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache
    Adult check-in
  8. 2021-02-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache, Fatigue or tiredness
    Adult check-in
  9. 2021-02-13
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-02-20
    Survey response — day 14, dose 1
    MedDRA: Headache, Respiratory tract congestion, Rhinorrhoea — Feeling: Good
    Free text: Runny nose, congestion, mild headache.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-02-27
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-03-01
    Dose 2 — Pfizer-BioNTech
  13. 2021-03-01
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-03-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  15. 2021-03-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache
    Adult check-in
  16. 2021-03-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-03-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-03-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  19. 2021-03-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  20. 2021-03-08
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-03-15
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-22
    Survey response — day 21, dose 2
    MedDRA: Blood glucose increased, Blood potassium decreased, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Bloodwork showed low potassium and slightly high glucose, two things Ive never had issues with. · Healthcare visit (other): Annual physical with primary care doctor
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-03-22
    Report sent to call center — day 21, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  24. 2021-03-29
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-04-05
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-04-12
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-05-31
    Survey response — 3 months, dose 2
    MedDRA: Biopsy, Breast mass, Office visit — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Two suspicious areas developed for the first time on my left breast. Both areas were determined to be benign after biopsies. · Healthcare visit (other): Underwent two rounds of mammography and two outpatient biopsies
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  28. 2021-05-31
    Report sent to call center — 3 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  29. 2021-08-30
    Health check-in — 6 months, dose 2
    Feeling: Poor
    Adult check-in
  30. 2021-10-21
    Dose 3 — Pfizer-BioNTech
  31. 2021-10-23
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  32. 2021-10-24
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  33. 2021-10-25
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Headache
    Adult check-in
  34. 2021-10-26
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  35. 2021-10-27
    Survey response — days 1–6 daily, dose 3
    MedDRA: Ear pain — Feeling: Good · Headache · Be unable to do your normal daily activities
    Free text: Earache
    MedDRA releases: 2024-11 · check-in free text available
  36. 2021-10-28
    Health check-in — day 7, dose 3
    Feeling: Good · Headache
    Adult check-in
  37. 2021-11-04
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  38. 2021-11-11
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  39. 2021-11-18
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  40. 2021-11-25
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  41. 2021-12-01
  42. 2021-12-02
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  43. 2021-12-02
  44. 2021-12-02
  45. 2022-01-20
    Survey response — 3 months, dose 3
    MedDRA: Headache, Oropharyngeal pain, Respiratory tract congestion — Feeling: Good
    Free text: Congestion, headache, mild sore throat
    MedDRA releases: 2024-11 · check-in free text available
  46. 2022-04-21
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  47. 2022-07-15
    Dose 4 — Pfizer-BioNTech
  48. 2022-07-16
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  49. 2022-07-17
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain · Joint pains, Fatigue or tiredness
    Adult check-in
  50. 2022-07-18
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  51. 2022-07-19
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  52. 2022-07-20
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  53. 2022-07-21
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  54. 2022-07-22
    Health check-in — day 7, dose 4
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  55. 2022-07-29
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  56. 2022-08-05
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  57. 2022-08-12
    Health check-in — day 28, dose 4
    Feeling: Fair
    Adult check-in
  58. 2022-08-19
    Health check-in — day 35, dose 4
    Feeling: Fair
    Adult check-in
  59. 2022-08-26
    Survey response — day 42, dose 4
    MedDRA: Diarrhoea, Oropharyngeal pain, Pyrexia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Sore throat, fever, diarrhea
    MedDRA releases: 2024-11 · check-in free text available
  60. 2022-08-26
    Report sent to call center — day 42, dose 4
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  61. 2022-08-29
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  62. 2022-08-29
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  63. 2022-08-29
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
  64. 2022-10-14
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  65. 2022-11-04
    Dose 5 — Pfizer-BioNTech
  66. 2022-11-04
    Health check-in — day 0, dose 5
    Feeling: Good · None
    Adult check-in
  67. 2022-11-05
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · Site: Pain, Itching · Fever · Headache, Fatigue or tiredness
    Adult check-in
  68. 2022-11-06
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · Site: Pain, Redness, Swelling, Itching · None
    Adult check-in
  69. 2022-11-07
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · Site: Pain, Redness, Itching · None
    Adult check-in
  70. 2022-11-08
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  71. 2022-11-09
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  72. 2022-11-10
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  73. 2022-11-11
    Survey response — day 7, dose 5
    MedDRA: Eye pain, Lacrimation increased, Ocular hyperaemia — Feeling: Fair · Headache · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Left eye - Bloodshot, watery, painful, possible discharge
    MedDRA releases: 2024-11 · check-in free text available
  74. 2022-11-11
    Report sent to call center — day 7, dose 5
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  75. 2022-11-15
  76. 2022-11-18
    Health check-in — day 14, dose 5
    Feeling: Good
    Adult check-in
  77. 2022-11-25
    Health check-in — day 21, dose 5
    Feeling: Good
    Adult check-in
  78. 2022-12-02
    Health check-in — day 28, dose 5
    Feeling: Good
    Adult check-in
  79. 2022-12-09
    Health check-in — day 35, dose 5
    Feeling: Good
    Adult check-in
  80. 2022-12-16
    Health check-in — day 42, dose 5
    Feeling: Good
    Adult check-in
  81. 2023-02-03
    Health check-in — 3 months, dose 5
    Feeling: Good
    Adult check-in
  82. 2023-05-05
    Survey response — 6 months, dose 5
    MedDRA: Pre-existing disease — Feeling: Poor
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12021-02-06Pfizer-BioNTech
22021-03-01Pfizer-BioNTech
32021-10-21Pfizer-BioNTech No
42022-07-15Pfizer-BioNTech No
52022-11-04Pfizer-BioNTech No

Call center

4 call center cases

3 successful · 1 unsuccessful

VAERS report filed, before or during a call: 2

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 4 — day 14, dose 1

2021-02-20

Symptoms: Runny nose, congestion, mild headache.

Release 6 — day 21, dose 2

2021-03-22

Symptoms: Bloodwork showed low potassium and slightly high glucose, two things Ive never had issues with.
Healthcare visit (other): Annual physical with primary care doctor

Release 8 — 3 months, dose 2

2021-05-31

Symptoms: Two suspicious areas developed for the first time on my left breast. Both areas were determined to be benign after biopsies.
Healthcare visit (other): Underwent two rounds of mammography and two outpatient biopsies

Release 10 — days 1–6 daily, dose 3

2021-10-27

Systemic reaction (other): Earache

Release 10 — 3 months, dose 3

2022-01-20

Symptoms: Congestion, headache, mild sore throat

Release 12 — day 42, dose 4

2022-08-26

Symptoms: Sore throat, fever, diarrhea

Release 12 — day 7, dose 5

2022-11-11

Systemic reaction (other): Left eye - Bloodshot, watery, painful, possible discharge

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOBiopsy ✓ ✓ ✓
HCVOOffice visit ✓ ✓ ✓
SDBlood glucose increased ✓ ✓ ✓
SDBlood potassium decreased ✓ ✓ ✓
SDBreast mass ✓ ✓ ✓
SDDiarrhoea · · ✓
SDHeadache ✓ ✓ ✓
SDOropharyngeal pain · · ✓
SDPre-existing disease · · ✓
SDPyrexia · · ✓
SDRespiratory tract congestion ✓ ✓ ✓
SDRhinorrhoea ✓ ✓ ✓
SROEar pain · · ✓
SROEye pain · · ✓
SROLacrimation increased · · ✓
SROOcular hyperaemia · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release